148 related articles for article (PubMed ID: 29883726)
1. Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum.
Jiménez-Antón MD; García-Calvo E; Gutiérrez C; Escribano MD; Kayali N; Luque-García JL; Olías-Molero AI; Corral MJ; Costi MP; Torrado JJ; Alunda JM
Eur J Pharm Sci; 2018 Aug; 121():281-286. PubMed ID: 29883726
[TBL] [Abstract][Full Text] [Related]
2. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
Reimão JQ; Oliveira JC; Trinconi CT; Cotrim PC; Coelho AC; Uliana SR
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003556. PubMed ID: 25679212
[TBL] [Abstract][Full Text] [Related]
3. LC-coupled ESI MS for quantification of miltefosine in human and hamster plasma.
Jaiswal S; Sharma A; Shukla M; Lal J
Bioanalysis; 2016 Mar; 8(6):533-45. PubMed ID: 26915470
[TBL] [Abstract][Full Text] [Related]
4. A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.
de Santana FR; da Silva DAM; Katz S; Orikaza CM; Oliveira KC; Barbiéri CL
Parasitol Res; 2022 Oct; 121(10):2849-2860. PubMed ID: 35997843
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.
Hendrickx S; Van den Kerkhof M; Mabille D; Cos P; Delputte P; Maes L; Caljon G
PLoS Negl Trop Dis; 2017 May; 11(5):e0005620. PubMed ID: 28505185
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.
Eberhardt E; Mondelaers A; Hendrickx S; Van den Kerkhof M; Maes L; Caljon G
Parasitol Res; 2016 Oct; 115(10):4061-70. PubMed ID: 27412759
[TBL] [Abstract][Full Text] [Related]
8. [Miltefosine: a new remedy for leishmaniasis].
Dorlo TP; Eggelte TA; Beijnen JH; de Vries PJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2697-701. PubMed ID: 17194005
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial.
Mbui J; Olobo J; Omollo R; Solomos A; Kip AE; Kirigi G; Sagaki P; Kimutai R; Were L; Omollo T; Egondi TW; Wasunna M; Alvar J; Dorlo TPC; Alves F
Clin Infect Dis; 2019 Apr; 68(9):1530-1538. PubMed ID: 30188978
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.
Hendrickx S; Mondelaers A; Eberhardt E; Delputte P; Cos P; Maes L
Antimicrob Agents Chemother; 2015 Aug; 59(8):4714-8. PubMed ID: 26014955
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.
Dorlo TP; van Thiel PP; Huitema AD; Keizer RJ; de Vries HJ; Beijnen JH; de Vries PJ
Antimicrob Agents Chemother; 2008 Aug; 52(8):2855-60. PubMed ID: 18519729
[TBL] [Abstract][Full Text] [Related]
12. Miltefosine to treat leishmaniasis.
Berman J
Expert Opin Pharmacother; 2005 Jul; 6(8):1381-8. PubMed ID: 16013987
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of the soluble proteomes of miltefosine-sensitive and -resistant Leishmania infantum chagasi isolates obtained from Brazilian patients with different treatment outcomes.
Carnielli JB; de Andrade HM; Pires SF; Chapeaurouge AD; Perales J; Monti-Rocha R; Carvalho SF; Ribeiro LP; Dietze R; Figueiredo SG; Lemos EM
J Proteomics; 2014 Aug; 108():198-208. PubMed ID: 24874972
[TBL] [Abstract][Full Text] [Related]
14. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA.
de Vries PJ; van der Meide WF; Godfried MH; Schallig HD; Dinant HJ; Faber WR
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1183-6. PubMed ID: 16678871
[TBL] [Abstract][Full Text] [Related]
16. Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.
Carvalho LM; Gusmão MR; Costa AFP; de Brito RCF; Aguiar-Soares RDO; Cardoso JMO; Reis AB; Carneiro CM; Roatt BM
Parasitology; 2022 Mar; 149(3):371-379. PubMed ID: 35264268
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis.
Voak AA; Harris A; Coteron-Lopez JM; Angulo-Barturen I; Ferrer-Bazaga S; Croft SL; Seifert K
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009013. PubMed ID: 33651812
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
Sane SA; Shakya N; Haq W; Gupta S
J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
[TBL] [Abstract][Full Text] [Related]
19. Natural Resistance of
Carnielli JBT; Monti-Rocha R; Costa DL; Molina Sesana A; Pansini LNN; Segatto M; Mottram JC; Costa CHN; Carvalho SFG; Dietze R
Am J Trop Med Hyg; 2019 Oct; 101(4):789-794. PubMed ID: 31436148
[TBL] [Abstract][Full Text] [Related]
20. Miltefosine-Lopinavir Combination Therapy Against
Rebello KM; Andrade-Neto VV; Gomes CRB; de Souza MVN; Branquinha MH; Santos ALS; Torres-Santos EC; d'Avila-Levy CM
Front Cell Infect Microbiol; 2019; 9():229. PubMed ID: 31316919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
